Erosive pustular dermatosis

Published on 16/03/2015 by admin

Filed under Dermatology

Last modified 16/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2007 times

Erosive pustular dermatosis

Bhavnit K. Bhatia and Jenny E. Murase

Evidence Levels:  A Double-blind study  B Clinical trial ≥ 20 subjects  C Clinical trial < 20 subjects  D Series ≥ 5 subjects  E Anecdotal case reports

image

Erosive pustular dermatosis of the scalp (EPDS) is a rare condition characterized by pustular, erosive, and crusted lesions in areas of alopecia that tend to be atrophic, actinically damaged, or both. The condition primarily affects the elderly, and has been documented to follow trauma to the scalp. EPDS lesions tend to be chronic, progressive, and difficult to treat. Laboratory and histopathological findings are not diagnostic.

Management strategy

Traditionally, potent topical corticosteroids have been used in EPDS with a generally positive but variable response within a few months of use. Due to steroid-related cutaneous atrophy, tacrolimus 0.1% ointment, calcipotriol cream, oral zinc, and photodynamic therapy have been introduced as alternative therapies. A recent series has shown dapsone 5% gel to be effective in resolving EPDS. Oral dapsone was shown in one case report to result in initial improvement, but the patient had problems with recurrence. Retinoids and oral corticosteroids have also shown some promise when used in conjunction with other topical antibiotics, topical corticosteroids, topical tacrolimus, oral dapsone, and oral zinc therapy. Topical and systemic antibiotics and antifungals are essentially ineffective.

First-line therapy

image High-potency topical corticosteroids D

Three series and 13 case reports exist for high potency topical cortisones in the literature.

Second-line therapies

image Topical 5% dapsone gel E
image Topical 0.1% tacrolimus ointment E

Buy Membership for Dermatology Category to continue reading. Learn more here